A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses
Food Chemistry Advances,
Journal Year:
2025,
Volume and Issue:
6, P. 100919 - 100919
Published: Feb. 11, 2025
Language: Английский
A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers
Ersen Kameri,
No information about this author
Vera H. Jepsen,
No information about this author
Paweł Stachura
No information about this author
et al.
Frontiers in Public Health,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 13, 2025
Childhood
leukemia
accounts
for
30%
of
all
pediatric
cancer
cases
with
acute
lymphoblastic
(ALL)
being
the
most
common
subtype.
Involvement
gut
microbiome
in
ALL
development
has
recently
garnered
interest
due
to
an
increasing
recognition
key
contribution
plays
maintaining
immune
system's
homeostatic
balance.
Commensal
microbiota
provide
a
first
line
defense
against
different
pathogens
and
immaturity
been
implicated
pathogenesis.
Several
environmental
factors
such
as
nutrition,
mode
delivery,
breastfeeding
and,
early
social
or
livestock
contacts
are
known
alter
composition
microbiota.
Variations
these
influence
risk
childhood
onset.
This
review
aims
elucidate
influencing
microbial
context
ALL.
The
link
between
diversity
offers
opportunity
develop
risk-reducing
strategies
that
can
be
communicated
broad
target
population
(future)
parents
caregivers
prevention.
Here,
we
summarize
evidence
on
how
promoting
diverse
newborns
through
simple
measures
life
may
decrease
developing
children
later
on.
Language: Английский
Probiotics and nanoparticle-mediated nutrient delivery in the management of transfusion-supported diseases
Wendao Han,
No information about this author
Nating Xiong,
No information about this author
Li‐Min Huang
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 11, 2025
Bone
marrow
is
vital
for
hematopoiesis,
producing
blood
cells
essential
oxygen
transport,
immune
defense,
and
clotting.
However,
disorders
like
leukemia,
lymphoma,
aplastic
anemia,
myelodysplastic
syndromes
can
severely
disrupt
its
function,
leading
to
life-threatening
complications.
Traditional
treatments,
including
chemotherapy
stem
cell
transplants,
have
significantly
improved
patient
outcomes
but
are
often
associated
with
severe
side
effects
limitations,
necessitating
the
exploration
of
safer,
more
targeted
therapeutic
strategies.
Nanotechnology
has
emerged
as
a
promising
approach
addressing
these
challenges,
particularly
in
delivery
nutraceuticals—bioactive
compounds
derived
from
food
sources
potential
benefits.
Despite
their
promise,
nutraceuticals
face
clinical
limitations
due
poor
bioavailability,
instability,
inefficient
target
sites.
Nanoparticles
offer
viable
solution
by
enhancing
stability,
absorption,
transport
bone
while
minimizing
systemic
effects.
This
study
explores
range
disorders,
conventional
treatment
modalities,
nanoparticles
enhance
nutraceutical-based
therapies.
By
improving
efficacy,
could
revolutionize
disease
management,
providing
patients
effective
less
invasive
options.
These
advancements
represent
significant
step
toward
safer
efficient
approaches,
ultimately
prognosis
overall
health.
Language: Английский
Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses
Immune Network,
Journal Year:
2024,
Volume and Issue:
24(6)
Published: Jan. 1, 2024
The
human
body
contains
a
diverse
array
of
microorganisms,
which
exert
significant
impact
on
various
physiological
processes,
including
immunity,
and
can
significantly
influence
susceptibility
to
diseases
such
as
cancer.
Recent
advancements
in
metagenomic
sequencing
have
uncovered
the
role
intratumoral
microbiome,
covertly
altered
development
cancer,
growth
tumors,
response
existing
treatments
through
multiple
mechanisms.
These
mechanisms
involve
mainly
DNA
damage
induction,
oncogenic
signaling
pathway
activation,
host's
immune
modulation.
To
explore
novel
therapeutic
options
effectively
target
regulate
comprehensive
understanding
these
processes
is
indispensable.
Here,
we
will
potential
actions
microbiome
concerning
initiation
progression
tumors.
We
examine
its
responses
chemotherapy,
radiotherapy,
immunotherapy.
Additionally,
discuss
current
state
knowledge
regarding
use
genetically
modified
bacteria
promising
treatment
option
for
Language: Английский